Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3608_Библиотеки_им_академика_М_И_Перельмана
.pdf
444
CH
35
F
E
FIGURE 358Cont'd E, Graft is
G
I
H
J
sutured to proximal descending thoracic
aorta. F, Clamps are repositioned to
restore perfusion of left subclavian
artery, left heart bypass is stopped, and
remainder of aneurysm is opened. G,
Dissecting membrane is removed to
allow identification of patent segmental
arteries and origins of visceral and
renal arteries. H, Blood from left heart
bypass circuit is delivered to celiac axis
and superior mesenteric artery (SMA)
via balloon perfusion catheters. Cold
crystalloid is delivered to kidneys through
catheters placed in renal arterial ostia.
Critical intercostal arteries are attached to
an opening in graft. I, Reattachment of
visceral branches and (J) the distal aortic
anastomosis complete the repair.
Box 35-4 Strategies for Spinal Cord, Visceral, and
Renal Protection During Repair of Distal
Thoracic Aortic Dissection
All Extents
Permissive mild hypothermia (32°C-34°C, nasopharyngeal)
Moderate heparinization
Aggressive reattachment of segmental arteries (especially T8-L1)
Sequential aortic clamping when possible
Perfusion of renal arteries with 4°C crystalloid solution when possible
Extent I and II Thoracoabdominal Repairs
Cerebrospinal fluid drainage
Left heart bypass during proximal anastomosis
Selective perfusion of celiac axis and superior mesenteric artery (SMA)
during intercostal and visceral/renal anastomoses
OUTCOMES
When performed in specialized centers, these operations achieve
excellent survival with acceptable morbidity.
tality for chronic distal dissection repair ranges from 6% to 10%.
Predictors of operative mortality include increasing age, congestive
heart failure (CHF), aortic rupture (contained or free), and preoperative renal failure. Risk of paraplegia or paraparesis is 3% to 9%. These
outcomes are significantly better than those obtained in patients who
undergo surgery during the acute phase. For example, comparative
67,77,78,81,93–95
Early mor-
results in patients who require replacement of the entire thoracoabdominal aorta (extent II repairs) in chronic versus acute settings
include early mortality in 5% versus 10%, paraplegia/paraparesis in
5% versus 11%, and renal failure in 13% versus 20%, respectively.
93
Postoperative Considerations
Postoperative management remains critical in optimizing organ outcomes and preventing morbidity. Maintaining organ perfusion while
preventing hypertension requires close monitoring. Aortic anastomoses are often extremely fragile during the early postoperative
period, especially after acute dissection repair. Even brief episodes
of postoperative hypertension can disrupt suture lines and precipitate severe bleeding or pseudoaneurysm formation. Therefore, during
the initial 24 to 48 hours, aggressive blood pressure control is maintained to protect the integrity of the anastomoses. Nitroprusside and
intravenous (IV) β-adrenoreceptor antagonists are routinely used to
maintain mean arterial blood pressure at 80 to 90 mmHg. In patients
with extremely friable aortic tissue, such as those with acute dissection or MFS, a lower target (70-80 mmHg) is used.
While preventing hypertensive episodes, maintaining adequate
blood pressure, preload, and cardiac inotropic state are important
in preventing delayed paraplegia and postoperative renal failure. In
the absence of postoperative bleeding, blood pressure should be
kept near its preoperative baseline level. Delayed paraplegia can
arise hours to days after aortic surgery. In the postoperative period,

strategies to reverse paraplegia include inducing systemic hyper-
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
tension, decreasing cerebrospinal pressure by cerebrospinal fluid
drainage, correcting anemia, preventing fever, and administering
cardiac inotropes, mannitol, and steroids.
96
Recovery from paraplegia is possible, but if cord function does not return promptly after
these measures are taken, such a recovery is not likely.
Aortic graft infections are a threat to anastomotic integrity and are
associated with extremely high morbidity and mortality.97 Definitive
treatment often requires complete removal of the graft and complex
vascular reconstruction. In an attempt to prevent this complication,
administration of IV antibiotics is recommended until all drains,
chest tubes, and central venous lines are removed. Similarly, all postoperative infections are treated aggressively with parenteral antibiotics to minimize the risk of secondary graft infection.
Vocal cord paresis is not uncommon after dissection at the distal arch. Resulting hoarseness is a concern that affects both voice
and postoperative pulmonary toilet (owing to ineffective cough).
Thyroplasty can improve functional status and is performed early
before discharge.
98
An exception would be in the event of anticipated reintubation for a planned subsequent operation, such as
completion of an elephant trunk. Reintubation can potentially disturb the thyroplasty, in these cases, initial vocal fold medialization
can be achieved via collagen injection, and definitive thyroplasty
can be performed at a later time.
The View Ahead
The landscape of thoracic aortic surgery is changing rapidly. As
patient age and disease complexity continue to increase, new
challenges are being met with innovative treatment strategies and
technological advances. As we gain experience with endovascular aortic stent-grafts, new indications are being explored (see
Chapter 36). The role of stent-grafts continues to expand in both
the hybrid setting and stand-alone situations. Improvements in our
understanding of the molecular mechanisms of dissection may
lead to novel forms of medical treatment aimed at reducing the
rate of aortic expansion and risk of fatal rupture.
Acknowledgments
The authors express gratitude to Chrissie Chambers, MA, ELS, and Stephen
N. Palmer, PhD, ELS, of the Texas Heart Institute, and Susan Y. Green,
MPH, for editorial assistance; and Scott A. Weldon, MA, CMI, and
Carol Lawson, CMI, for creating illustrations and assisting with image
selection.
REFERENCES
1. Hiratzka LF, Bakris GL, Beckman JA, et al: 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/
STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic
disease: a report of the American College of Cardiology Foundation/American Heart
Association Task Force on Practice Guidelines, American Association for Thoracic Surgery,
American College of Radiology, American Stroke Association, Society of Cardiovascular
Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of
Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine,
Circulation 121(13):e266–e369, 2010.
2. Fann JI, Miller DC: Aortic dissection, Ann Vasc Surg 9(3):311–323, 1995.
3. Ehrlich MP, Ergin MA, McCullough JN, et al: Results of immediate surgical treatment of all
acute type A dissections, Circulation 102(19 Suppl 3):III248–III252, 2000.
4. Estrera AL, Huynh TT, Porat EE, et al: Is acute type A aortic dissection a true surgical
emergency? Semin Vasc Surg 15(2):75–82, 2002.
5. Piccardo A, Regesta T, Pansini S, et al: Should octogenarians be denied access to surgery
for acute type A aortic dissection? J Cardiovasc Surg (Torino) 50(2):205–212, 2009.
6. Piccardo A, Regesta T, Zannis K, et al: Outcomes after surgical treatment for type A acute
aortic dissection in octogenarians: a multicenter study, Ann Thorac Surg 88(2):491–497,
2009.
7. Neri E, Toscano T, Massetti M, et al: Operation for acute type A aortic dissection in
octogenarians: is it justified? J Thorac Cardiovasc Surg 121(2):259–267, 2001.
8. Wu IH, Yu HY, Liu CH, et al: Is old age a contraindication for surgical treatment in acute
aortic dissection? A demographic study of national database registry in Taiwan, J Card
Surg 23(2):133–139, 2008.
9. Fehrenbacher J, Halbrook H, Siderys H: Operation for acute type A aortic dissection in
octogenarians: is it justified? J Thorac Cardiovasc Surg 123(2):393–394, 2002.
10. McK neally MF: “ We don't do that here”: reflections on the Siena experience with dissecting
aneurysms of the thoracic aorta in octogenarians, J Thorac Cardiovasc Surg 121(2):202–
203, 2001.
11. Westaby S, Saito S, Katsumata T: Acute type A dissection: conservative methods provide
consistently low mortality, Ann Thorac Surg 73(3):707–713, 2002.
12. Deeb GM, Williams DM, Bolling SF, et al: Surgical delay for acute type A dissection with
malperfusion, Ann Thorac Surg 64(6):1669–1675, 1997.
13. Fabre O, Vincentelli A, Willoteaux S, et al: Preoperative fenestration for type A acute aortic
dissection with mesenteric malperfusion, Ann Thorac Surg 73(3):950–951, 2002.
14. Collins JS, Evangelista A, Nienaber CA, et al: Differences in clinical presentation,
management, and outcomes of acute type a aortic dissection in patients with and
without previous cardiac surgery, Circulation 110(11 Suppl 1):II237–II242, 2004.
15. Hassan M, Carvalho EM, Macedo FI, et al: Paradigm change in the management of patients
with acute type A aortic dissection who had prior cardiac surgery, J Card Surg 25(4):
387–389, 2010.
16. Gillinov AM, Lytle BW, Kaplon RJ, et al: Dissection of the ascending aorta after previous
cardiac surgery: differences in presentation and management, J Thorac Cardiovasc Surg
117(2):252–260, 1999.
17. Murphy DA, Craver JM, Jones EL, et al: Recognition and management of ascending aortic
dissection complicating cardiac surgical operations, J Thorac Cardiovasc Surg 85(2):
247–256, 1983.
18. Estrera AL, Miller CC, Kaneko T, et al: Outcomes of acute type a aortic dissection after
previous cardiac surgery, Ann Thorac Surg 89(5):1467–1474, 2010.
19. Birkmeyer JD, Stukel TA, Siewers AE, et al: Surgeon volume and operative mortality in the
United States, N Engl J Med 349(22):2117–2127, 2003.
20. Cowan JA Jr, Dimick JB, Henke PK, et al: Surgical treatment of intact thoracoabdominal
aortic aneurysms in the United States: hospital and surgeon volume-related outcomes,
J Vasc Surg 37(6):1169–1174, 2003.
21. Miyata H, Motomura N, Ueda Y, et al: Toward quality improvement of thoracic aortic
surgery: estimating volume-outcome effect from nationwide survey, Eur J Cardiothorac
Surg 36(3):517–521, 2009.
22. Garcia-Jimenez A, Peraza Torres A, Martinez Lopez G, et al: Cardiac tamponade by aortic
dissection in a hospital without cardiothoracic surgery, Chest 104(1):290–291, 1993.
23. Perez L, Wise L: A standardized treatment protocol for blood pressure management in
transport patients with a reported diagnosis of acute aortic dissection or symptomatic
aortic aneurysm, Air Med J 18(3):111–113, 1999.
24. Knobloch K, Dehn I, Khaladj N, et al: HEMS vs. EMS transfer for acute aortic dissection type
A, Air Med J 28(3):146–153, 2009.
25. Bavaria JE, Brinster DR, Gorman RC, et al: Advances in the treatment of acute type A
dissection: an integrated approach, Ann Thorac Surg 74(5):S1848–S1852, 2002.
26. Deeb GM, Williams DM, Quint LE, et al: Risk analysis for aortic surgery using hypothermic
circulatory arrest with retrograde cerebral perfusion, Ann Thorac Surg 67(6):1883–1886,
1999; discussion 91–4.
27. Kazui T, Washiyama N, Bashar AH, et al: Surgical outcome of acute type A aortic dissection:
analysis of risk factors, Ann Thorac Surg 74(1):75–81, 2002.
28. Wong DR, Coselli JS, Palmero L, et al: Axillary artery cannulation in surgery for acute or
subacute ascending aortic dissections, Ann Thorac Surg 90(3):731–737, 2010.
29. Kamiya H, Kallenbach K, Halmer D, et al: Comparison of ascending aorta versus femoral
artery cannulation for acute aortic dissection type A, Circulation 120(11 Suppl):S282–S286,
2009.
30. Coselli JS, Crawford ES, Beall AC Jr, et al: Determination of brain temperatures for safe
circulatory arrest during cardiovascular operation, Ann Thorac Surg 45(6):638–642,
1988.
31. Svensson LG, Crawford ES, Hess KR, et al: Deep hypothermia with circulatory arrest:
determinants of stroke and early mortality in 656 patients, J Thorac Cardiovasc Surg
106(1):19–28, 1993.
32. Coselli JS, LeMaire SA: Experience with retrograde cerebral perfusion during proximal
aortic surgery in 290 patients, J Card Surg 12(2 Suppl):322–325, 1997.
33. Hagl C, Khaladj N, Karck M, et al: Hypothermic circulatory arrest during ascending and
aortic arch surgery: the theoretical impact of different cerebral perfusion techniques and
other methods of cerebral protection, Eur J Cardiothorac Surg 24(3):371–378, 2003.
34. Moon MR, Sundt TM III: Influence of retrograde cerebral perfusion during aortic arch
procedures, Ann Thorac Surg 74(2):426–431, 2002.
35. Wong CH, Bonser RS: Retrograde cerebral perfusion: clinical and experimental aspects,
Perfusion 14(4):247–256, 1999.
36. Kazui T, Yamashita K, Washiyama N, et al: Usefulness of antegrade selective cerebral
perfusion during aortic arch operations, Ann Thorac Surg 74(5):S1806–S1809, 2002.
37. Matalanis G, Hata M, Buxton BF: A retrospective comparative study of deep hypothermic
circulatory arrest, retrograde, and antegrade cerebral perfusion in aortic arch surgery, Ann
Thorac Cardiovasc Surg 9(3):174–179, 2003.
38. Pasic M, Schubel J, Bauer M, et al: Cannulation of the right axillary artery for surgery of
acute type A aortic dissection, Eur J Cardiothorac Surg 24(2):231–235, 2003; discussion 5–6.
39. Sabik JF, Lytle BW, McCarthy PM, et al: Axillary artery: an alternative site of arterial
cannulation for patients with extensive aortic and peripheral vascular disease, J Thorac
Cardiovasc Surg 109(5):885–890, 1995; discussion 90–1.
40. Leshnower BG, Myung RJ, Kilgo PD, et al: Moderate hypothermia and unilateral selective
antegrade cerebral perfusion: a contemporary cerebral protection strategy for aortic arch
surgery, Ann Thorac Surg 90(2):547–554, 2010.
41. Crawford ES, Kirklin JW, Naftel DC, et al: Surgery for acute dissection of ascending aorta:
should the arch be included? J Thorac Cardiovasc Surg 104(1):46–59, 1992.
42. LeMaire SA, Price MD, Parenti JL, et al: Early outcomes after aortic arch replacement by
using the Y-graft technique, Ann Thorac Surg 91(3):700–708, 2011.
43. Borst HG, Frank G, Schaps D: Treatment of extensive aortic aneurysms by a new multiplestage approach, J Thorac Cardiovasc Surg 95(1):11–13, 1988.
44. Schepens MA, Dossche KM, Morshuis WJ, et al: The elephant trunk technique: operative
results in 100 consecutive patients, Eur J Cardiothorac Surg 21(2):276–281, 2002.
45. Fattouch K, Sampognaro R, Navarra E, et al: Long-term results after repair of type a acute
aortic dissection according to false lumen patency, Ann Thorac Surg 88(4):1244–1250,
2009.
46. Song JM, Kim SD, Kim JH, et al: Long-term predictors of descending aorta aneurysmal
change in patients with aortic dissection, J Am Coll Cardiol 50(8):799–804, 2007.
445
CH
35
SURGICAL THERAPY FOR AORTIC DISSECTION

446
47. Song SW, Chang BC, Cho BK, et al: Effects of partial thrombosis on distal aorta after repair
of acute DeBakey type I aortic dissection, J Thorac Cardiovasc Surg 139(4):841–847 e1,
2010; discussion 7.
48. Gorlitzer M, Weiss G, Meinhart J, et al: Fate of the false lumen after combined surgical
and endovascular repair treating Stanford type A aortic dissections, Ann Thorac Surg
89(3):794–799, 2010.
49. Jazayeri S, Tatou E, Gomez MC, et al: Combined treatment of aortic type A dissection:
CH
35
ascending aorta repair and placement of a stent in the descending aorta, Heart Surg
Forum 6(5):387–389, 2003.
50. Pochettino A, Brinkman WT, Moeller P, et al: Antegrade thoracic stent grafting during
repair of acute DeBakey I dissection prevents development of thoracoabdominal aortic
aneurysms, Ann Thorac Surg 88(2):482–489, 2009; discussion 9–90.
51. Fann JI, Glower DD, Miller DC, et al: Preservation of aortic valve in type A aortic dissection
complicated by aortic regurgitation, J Thorac Cardiovasc Surg 102(1):62–73, 1991;
discussion -5.
52. Murashita T, Kunihara T, Shiiya N, et al: Is preservation of the aortic valve different between
acute and chronic type A aortic dissections? Eur J Cardiothorac Surg 20(5):967–972, 2001.
53. K irsch M, Soustelle C, Houel R, et al: Risk factor analysis for proximal and distal reoperations
after surgery for acute type A aortic dissection, J Thorac Cardiovasc Surg 123(2):318–325,
2002.
54. Piccardo A, Regesta T, Pansini S, et al: Fate of the aortic valve after root reconstruction in
type A aortic dissection: a 20-year follow up, J Heart Valve Dis 18(5):507–513, 2009.
55. Erasmi AW, Stierle U, Bechtel JF, et al: Up to 7 years’ experience with valve-sparing aortic
root remodeling/reimplantation for acute type A dissection, Ann Thorac Surg 76(1):
99–104, 2003.
56. Kallenbach K, Pethig K, Leyh RG, et al: Acute dissection of the ascending aorta: first results
of emergency valve sparing aortic root reconstruction, Eur J Cardiothorac Surg 22(2):218–
222, 2002.
57. Kerendi F, Guyton RA, Vega JD, et al: Early results of valve-sparing aortic root replacement
in high-risk clinical scenarios, Ann Thorac Surg 89(2):471–476, 2010; discussion 7–8.
58. von Segesser LK, Lorenzetti E, Lachat M, et al: Aortic valve preservation in acute type A
dissection: is it sound? J Thorac Cardiovasc Surg 111(2):381–390, 1996; discussion 90–1.
59. Bachet J: Acute type A aortic dissection: can we dramatically reduce the surgical
mortality? Ann Thorac Surg 73(3):701–703, 2002.
60. Stevens LM, Madsen JC, Isselbacher EM, et al: Surgical management and long-term
outcomes for acute ascending aortic dissection, J Thorac Cardiovasc Surg 138(6):
1349–1357 e1, 2009.
61. Masuda Y, Yamada Z, Morooka N, et al: Prognosis of patients with medically treated aortic
dissections, Circulation 84(5 Suppl):III7–III13, 1991.
62. Trimarchi S, Eagle KA, Nienaber CA, et al: Role of age in acute type A aortic dissection
outcome: report from the International Registry of Acute Aortic Dissection (IRAD),
J Thorac Cardiovasc Surg 140(4):784–789, 2010.
63. Fann JI, Smith JA, Miller DC, et al: Surgical management of aortic dissection during a
30-year period, Circulation 92(9 Suppl):II113–II121, 1995.
64. Pansini S, Gagliardotto PV, Pompei E, et al: Early and late risk factors in surgical treatment
of acute type A aortic dissection, Ann Thorac Surg 66(3):779–784, 1998.
65. Kimura N, Tanaka M, Kawahito K, et al: Influence of patent false lumen on long-term
outcome after surgery for acute type A aortic dissection, J Thorac Cardiovasc Surg
136(5):1160–1166, 6 e1–6 e3, 2008.
66. Kazui T, Yamashita K, Washiyama N, et al: Impact of an aggressive surgical approach on
surgical outcome in type A aortic dissection, Ann Thorac Surg 74(5):S1844–S1847, 2002;
discussion S57–63.
67. Safi HJ, Miller CC III, Reardon MJ, et al: Operation for acute and chronic aortic dissection:
recent outcome with regard to neurologic deficit and early death, Ann Thorac Surg
66(2):402–411, 1998.
68. Fattori R, Tsai TT, Myrmel T, et al: Complicated acute type B dissection: is surgery still the
best option? A report from the International Registry of Acute Aortic Dissection, JACC
Cardiovasc Interv 1(4):395–402, 2008.
69. Hagan PG, Nienaber CA, Isselbacher EM, et al: The International Registry of Acute Aortic
Dissection (IRAD): new insights into an old disease, JAMA 283(7):897–903, 2000.
70. Elefteriades JA, Hartleroad J, Gusberg RJ, et al: Long-term experience with descending
aortic dissection: the complication-specific approach, Ann Thorac Surg 53(1):11–20, 1992.
71. Umana JP, Lai DT, Mitchell RS, et al: Is medical therapy still the optimal treatment strategy
for patients with acute type B aortic dissections? J Thorac Cardiovasc Surg 124(5):896–910,
2002.
72. Chavan A, Lotz J, Oelert F, et al: Endoluminal treatment of aortic dissection, Eur Radiol
13(11):2521–2534, 2003.
73. Vedantham S, Picus D, Sanchez LA, et al: Percutaneous management of ischemic
complications in patients with type-B aortic dissection, J Vasc Interv Radiol 14(2 Pt 1):181–
194, 2003.
74. Kische S, Ehrlich MP, Nienaber CA, et al: Endovascular treatment of acute and chronic
aortic dissection: midterm results from the Talent Thoracic Retrospective Registry,
J Thorac Cardiovasc Surg 138(1):115–124, 2009.
75. Nienaber CA, Rousseau H, Eggebrecht H, et al: Randomized comparison of strategies for
type B aortic dissection: the INvestigation of STEnt Grafts in Aortic Dissection (INSTEAD)
trial, Circulation 120(25):2519–2528, 2009.
76. Panneton JM, Teh SH, Cherry KJ Jr, et al: Aortic fenestration for acute or chronic aortic
dissection: an uncommon but effective procedure, J Vasc Surg 32(4):711–721, 2000.
77. Gysi J, Schaffner T, Mohacsi P, et al: Early and late outcome of operated and non-operated
acute dissection of the descending aorta, Eur J Cardiothorac Surg 11(6):1163–1169, 1997.
78. Coselli JS, LeMaire SA, de Figueiredo LP, et al: Paraplegia after thoracoabdominal aortic
aneurysm repair: is dissection a risk factor? Ann Thorac Surg 63(1):28–35, 1997.
79. Kouchoukos NT, Masetti P, Rokkas CK, et al: Hypothermic cardiopulmonary bypass and
circulatory arrest for operations on the descending thoracic and thoracoabdominal aorta,
Ann Thorac Surg 74(5):S1885–S1887, 2002.
80. Lansman SL, Hagl C, Fink D, et al: Acute type B aortic dissection: surgical therapy, Ann
Thorac Surg 74(5):S1833–S1835, 2002; discussion S57–63.
81. Svensson LG, Crawford ES, Hess KR, et al: Dissection of the aorta and dissecting aortic
aneurysms: improving early and long-term surgical results, Circulation 82(5 Suppl):IV24–
IV38, 1990.
82. Glower DD, Speier RH, White WD, et al: Management and long-term outcome of aortic
dissection, Ann Surg 214(1):31–41, 1991.
83. Svensson LG, Hess KR, Coselli JS, et al: A prospective study of respiratory failure after highrisk surgery on the thoracoabdominal aorta, J Vasc Surg 14(3):271–282, 1991.
84. Engle J, Safi HJ, Miller CC III, et al: The impact of diaphragm management on prolonged
ventilator support after thoracoabdominal aortic repair, J Vasc Surg 29(1):150–156, 1999.
85. LeMaire SA, Miller CC III, Conklin LD, et al: A new predictive model for adverse outcomes
after elective thoracoabdominal aortic aneurysm repair, Ann Thorac Surg 71(4):1233–
1238, 2001.
86. Coselli JS, Conklin LD, LeMaire SA: Thoracoabdominal aortic aneurysm repair: review and
update of current strategies, Ann Thorac Surg 74(5):S1881–S1884, 2002; discussion S92–8.
87. Coselli JS, LeMaire SA: Surgical techniques: thoracoabdominal aorta, Cardiol Clin
17(4):751–765, 1999.
88. LeMaire SA, Jamison AL, Carter SA, et al: Deployment of balloon expandable stents during
open repair of thoracoabdominal aortic aneurysms: a new strategy for managing renal
and mesenteric artery lesions, Eur J Cardiothorac Surg 26(3):599–607, 2004.
89. Coselli JS, LeMaire SA, Köksoy C, et al: Cerebrospinal fluid drainage reduces paraplegia
after thoracoabdominal aortic aneurysm repair: results of a randomized clinical trial, J
Vasc Surg 35(4):631–639, 2002.
90. Coselli JS, LeMaire SA: Left heart bypass reduces paraplegia rates after thoracoabdominal
aortic aneurysm repair, Ann Thorac Surg 67(6):1931–1934, 1999.
91. Köksoy C, LeMaire SA, Curling PE, et al: Renal perfusion during thoracoabdominal
aortic operations: cold crystalloid is superior to normothermic blood, Ann Thorac Surg
73(3):730–738, 2002.
92. LeMaire SA, Jone MM, Conklin LD, et al: Randomized comparison of cold blood and cold
crystalloid renal perfusion for renal protection during thoracoabdominal aortic aneurysm
repair, J Vasc Surg 49:11–19, 2009.
93. Coselli JS, LeMaire SA, Conklin LD, et al: Morbidity and mortality after extent II
thoracoabdominal aortic aneurysm repair, Ann Thorac Surg 73(4):1107–1116, 2002.
94. Coselli JS, Bozinovski J, LeMaire SA: Open surgical repair of 2286 thoracoabdominal aortic
aneurysms, Ann Thorac Surg 83:S862–S864, 2007.
95. Estrera AL, Miller CC III, Huynh TT, et al: Preoperative and operative predictors of delayed
neurologic deficit following repair of thoracoabdominal aortic aneurysm, J Thorac
Cardiovasc Surg 126(5):1288–1294, 2003.
96. Wong DR, Coselli JS, Amerman K, et al: Delayed spinal cord deficits after thoracoabdominal
aortic aneurysm repair, Ann Thorac Surg 83(4):1345–1355, 2007.
97. Coselli JS, Köksoy C, LeMaire SA: Management of thoracic aortic graft infections, Ann
Thorac Surg 67(6):1990–1993, 1999.
98. Rosingh HJ, Dikkers FG: Thyroplasty to improve the voice in patients with a unilateral
vocal fold paralysis, Clin Otolaryngol Allied Sci 20(2):124–126, 1995.
99. Girdauskas E, Kuntze T, Borger MA, et al: Surgical risk of preoperative malperfusion in
acute type A aortic dissection, J Thorac Cardiovasc Surg 138(6):1363–1369, 2009.
100. Goda M, Imoto K, Suzuki S, et al: Risk analysis for hospital mortality in patients with acute
type a aortic dissection, Ann Thorac Surg 90(4):1246–1250, 2010.

CHAPTER
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
36 Endovascular Therapy for Aortic
Dissection
Michael D. Dake
Acute aortic dissection (AAD) is a precipitous event associated
with a wide range of outcomes from uncomplicated to catastrophic. Current endovascular strategies are based on identifying
features that portend increased risk of death or other poor outcome and applying interventional techniques to prevent the lifethreatening complications of the dissection.
During the last 2 decades, there has been increasing interest
in exploring endovascular procedures for management of aortic
dissection.
addressing branch vessel involvement and ischemic complications
associated with the dissection process
endovascular aortic stent grafts (initially developed to repair aortic aneurysms) were applied in type B aortic dissection to cover
the primary entry tear of the dissection and promote thrombosis of
the thoracic aortic false lumen
cular tactics are now routine in the contemporary armamentarium
for treatment of aortic dissection and its myriad manifestations.
Endovascular approaches are complementary to the two traditional therapeutic paradigms of open surgical repair for type A dissection and medical treatment for uncomplicated type B disease.
Invasive interventional procedures fit between the existing operative and noninvasive alternatives to provide effective options for
type A dissection with severe branch vessel compromise (before
or after ascending aortic repair), complicated type B dissection
(branch vessel involvement, descending aortic rupture, extension of disease or early aortic dilation, etc.), arch involvement, and
ascending aortic intramural hematoma associated with an intimal
tear distal to the left subclavian artery.
This chapter will review the specific endovascular procedures
currently in use to manage aortic dissection, the patient subgroups
in which these techniques are commonly employed, and the
outcomes of these interventions.
4–13
Initially, endovascular approaches focused on
4,5
(Fig. 36-2). These basic endovas-
1–3
8,9
(Fig. 36-1). Subsequently,
Branch Vessel Interventions
Branch vessel involvement accompanying aortic dissection
is a well-recognized complication occurring in over 30% of
7,8,14
cases.
tomical concepts of static and dynamic branch involvement are
crucial to selection of the endovascular option for reperfusion of
an affected vascular bed.
distally from the primary entry tear, the dissection septum may
engage the ostia of branch vessels. If the aortic flap, which consists of the intima and portion of the media shorn away from the
wall, engages a branch orifice as it extends, two pathophysiological situations referred to respectively as static and dynamic branch
involvement may occur (
Static Branch Involvement
One manifestation that may arise when the advancing dissection
septum intersects an aortic branch is static branch vessel involvement (
extends directly into the branch for a variable distance. In contrast
to the geometry described earlier, orientation of the septal trajectory is such that the branch ostium is incompletely engaged by the
edge of the dissection plane. Rather than being circumferentially
shorn by the septum, there is only partial circumferential involvement of the branch by the dissection. The aortic flap extends into
the branch, creating a false lumen within the artery. As a result, the
individual branch has both a true and false lumen like the aorta.
For appropriate intervention selection, the pathoana-
15–17
As the dissection process extends
Fig. 36-3).
Fig. 36-4). In static involvement, the aortic dissection flap
Similar to the aorta, a branch affected by static involvement may
have multiple fates. At the end of the dissection where the flap terminates in the branch, a reentry tear in the false lumen may or may
not occur. If a reentry tear occurs at the end of the false lumen,
branch perfusion results from blood flow in both the true and false
lumens. In many such cases, dual lumen perfusion is not associated with ischemic branch vessel symptoms. If reentry does not
occur in cases of static branch vessel involvement, however, the
false lumen within the branch has no outflow. The absence of a
distal tear to allow communication with the vascular bed beyond
the dissection may impair blood flow significantly. This no reen-
try state within the branch's false lumen renders perfusion limited to that contributed by the true lumen. Unfortunately, the true
lumen may be compromised by the engorged false lumen. The
blind pouch of the false lumen, without outflow, swells to a maximum dimension at its distal end. The pressure exerted by the false
lumen severely distorts and compresses the true lumen to markedly reduce branch vessel flow. Commonly, the degree of ischemia
experienced by the involved vascular bed may be significant and
can lead to irreversible tissue necrosis if not relieved quickly.
In no-reentry situations, a local solution directed at improving
flow within the affected artery is required because the problem is
localized within the specific branch. Two options for endovascular treatment are possible. Resistance to outflow within the false
lumen may be decreased by creating a distal tear or fenestration
within the blind channel. This can be accomplished with the end
of a guidewire or other endovascular probe placed within the false
lumen through the aortic false lumen. This approach is associated with practical challenges, including the avoidance of distal
extension of the dissection process, safe penetration of the false
lumen wall to create an effective outflow tear, and determination
of the presence of thrombus within the blind sac of stagnant false
lumen blood to avoid its distal embolization.
In most cases, the preferred strategy involves increasing branch
flow by decreasing the resistance to true lumen blood flow. This
is performed by placing a stent in the true lumen of the branch
through catheterization from the aortic true lumen. The stent is typically placed from beyond the end of the false lumen in the branch
back to the aortic true lumen. A self-expanding nitinol stent is
commonly employed because this distance is frequently greater
than 2 cm and because there is a risk of squeezing any existing
clot out of the false lumen with a balloon-expandable stent. These
stents are sized to the total transarterial diameter of the branch and
allowed to progressively expand on their own (post deployment)
without supplemental balloon dilation. There are many successful reports of this approach in mesenteric, renal, and iliac arteries
affected by no-reentry or static involvement.
Occasionally, static branch vessel involvement with reentry
anatomy and double-barrel flow may require endovascular intervention. The most common indication for stent placement in this
setting occurs with involvement of a renal artery (
kidney supplied by a dissected renal artery may be affected by the
physical presence of a flap within the branch. The variable flow
reduction caused by the flap, and resultant disrupted pattern of
true and false lumen perfusion, may contribute to an exacerbation
of hypertension. In cases where high blood pressure is sustained
and recalcitrant to numerous intravenous ( IV) medications, endovascular intervention may be warranted to restore a single lumen
without flap. The approach to treatment involves placement of a
balloon-expandable renal stent within the true lumen of the renal
artery through the aortic true lumen. In most cases, this type of
8,9,18,19
Fig. 36-5). The
447

448
CH
36
A B
FIGURE 361 Type B aortic dissection with proximal entry tear distal to left subclavian artery, retrograde extension, ascending intramural
hematoma, and rupture into left chest. A, Non–contrast-enhanced axial computed tomography (CT) image through the aorta demonstrates an ascending aortic
mural-based ring with increased density, indicative of intramural hematoma. Also apparent is abnormal extravascular tissue surrounding aorta, with characteristic
appearance of a rupture with clot. B, Series of images from a thoracic aortogram demonstrate entry tear just beyond left subclavian artery, with contrast media
opacifying both the true and false lumens. Precise point of rupture is not identified.
A B
FIGURE 362 Aortic dissection with rupture. A, Thoracic aortogram demonstrates type B aortic dissection with mid-descending aortic rupture. B, Repeat
aortogram following placement of thoracic endograft over proximal entry tear just above the site of rupture, without evidence of residual contrast extravasation.
TL
FL
A
FIGURE 363 A, Static obstruction. Dissection has extended into a branch vessel. B, Dynamic obstruction. Membrane is lying across and obstructing origin of
branch vessel. TL, true lumen; FL, false lumen.
B
FL
TL

ABC
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
FIGURE 364 Magnetic resonance imaging (MRI) of static branch vessel involvement of iliac arteries. A, Coronal image of pelvis identifies a flap extending
into right common iliac artery (CIA) and down to distal external iliac artery (EIA). Flow is evident in both true and false lumens within the right iliac artery. This is an
example of static involvement with direct flap extension from the aorta into a branch. At the end of the dissection within the EIA, there is a distal reentry tear. This
terminal tear establishes double-barrel flow within the iliac artery, which is rarely associated with ischemic symptoms. B-C, Similar coronal views show flap extension
into left iliac system, but a segmental flow void (black segment) within false lumen of left CIA. This is associated with a no-reentry situation at distal extent of false
lumen. No reentry within a branch is typically associated with obstruction of true lumen by a dilated false lumen cul-de-sac. The flow void noted may represent
thrombosis in a blind channel or simply no blood flow. The usual consequence of this phenomenon of no reentry is branch vessel ischemia due to a lack of false lumen
perfusion and compromised true lumen branch flow.
449
CH
36
EndovAsCulAR THERAPy foR AoRTiC dissECTion
Bilateral Renal Art cpr
A
FIGURE 365 Computed tomography (CT) images of true and false lumen relationships to renal arteries. Axial (A) and coronal (B) CT images at level
of left renal artery show that left renal artery is supplied by the false lumen (left aortic lumen). True lumen is located along right wall of aorta, and flap shows a
characteristic natural fenestration or defect corresponding to left renal ostium. Flap around fenestration has small tail-like extensions pointing to the left that represent
the initial few millimeters of left renal intimal lining that were torn away with the retracted aortic septum.
reentry involvement does not extend into the branch as far as the
no-reentry extension. Thus, stents less than 2-cm long are typically
implanted. This technique is well established at most centers that
manage cases of aortic dissection frequently.
B
distally. The cleavage plane extends 1 to 2 mm into the branch, and
then circumferentially reenters, creating a cylindrical tear, coring
out a short segment of the intimal/medial lining of the most proximal aspect of the branch. The septum retracts into the aortic lumen
with a fenestration corresponding to the branch orifice. This gives
Dynamic Branch Involvement
In addition to primary branch pathology that occurs as a complication of aortic dissection, another mechanism, dynamic
branch vessel involvement, may be responsible for organ ischemia. Dynamic branch involvement is a phenomenon associated
with obstruction to branch vessel flow by an aortic septum that
has prolapsed over the branch ostia like a curtain. In contrast to
static involvement, where the aortic flap extends directly into a
branch, dynamic obstruction occurs as an aortic process exclusively without an associated branch lesion. Propagation of the aortic flap may create a circumferential cleavage of the aortic wall
surrounding the branch ostium (Fig. 36-6). Factors associated
with this event include the flap trajectory, the resultant orientation
of the septal plane proximal to the branch, and the inclusion of
the ostium by the cleaved flap as it extends past. In this situation,
the dissection septum surrounds the branch ostium as it tears
the flap a stencil-like appearance when viewed en face, with the
number of holes related to the number of branch vessels involved
by this phenomenon. When imaged in an axial plane, the affected
artery appears to originate exclusively from the aortic false lumen.
Closer inspection usually allows identification of a tear in the flap
at the level or adjacent to the level of the branch. The flap often
displays small projections angled from the edge of the tear, giving
its outline on axial imaging an appearance similar to the contour
of a metal rivet, the short-legged extensions corresponding to the
amputated proximal lining of the branch.
In dynamic branch obstruction, hemodynamic flow patterns
result in a large aortic false lumen with a diminutive or collapsed true lumen. There is variability, however, in the degree
of true lumen obliteration related to the dynamic compromise.
In the majority of aortic dissection cases with true and false
lumen aortic flow (often called double-barrel flow), the process
described does not cause critical branch perfusion abnormalities.

450
AB
CD
CH
36
FIGURE 366 Magnetic resonance
imaging (MRI) demonstrates dynamic branch vessel involvement,
with aortic true lumen collapse and
accompanying static no-reentry
obstruction of left common iliac
artery (CIA). A-C, Axial MRI shows
wafer-thin crescent-shaped true lumen
collapsed against anterior aortic wall at
level of visceral arteries. Aortic septum
prolapses like a curtain across the origins
of branches originating from true
lumen, with resultant malperfusion and
multiorgan ischemia. D, At the level just
below aortic bifurcation, there is marked
asymmetry in appearance of CIAs.
Lumen of left CIA has a flow void (black
circle) due to static involvement without
reentry that coexists with the dynamic
process observed more proximally.
Flow to the branch originates primarily from the false lumen, with a
small contribution from the true lumen through the corresponding
fenestration in the aortic septum. Most of the false lumen flow usually occurs in diastole. During systole, the small contribution from
the true lumen arrives through the septal window into the false
lumen and branch. If the proximal primary tear is very large or the
entry tear is in close proximity to the branch, the dominant flow
pattern supplying branch perfusion may be in systole. In general,
a branch that originates exclusively from the aortic false lumen is
rarely affected by an ischemic complication.
Consistently, the aortic septum prolapses with a convex contour
an obliterated aortic true lumen that supplies the compromised
branches is most expeditiously and effectively approached by an
endovascular aortic procedure rather than a strategy directed at
the individual branches.
More than one mechanism of branch involvement can coexist
in any given patient. The clinical manifestations and the analysis of
imaging for any patient requires an individualized approach that
must synthesize information and aortic and branch vessel involvement to customize an optimal treatment strategy that will safely,
successfully, and durably address the most compelling effects of
the dissection.
toward a compromised crescent-shaped true lumen. Consequently,
all branches originating from the true lumen are at risk of obstruction. In this regard, the aortic septum in a dynamic obstructive
process often assumes a coronal position, oriented across the
aorta from left to right, in the distal descending thoracic proximal
abdominal aortic segments. Consequently, the anteriorly oriented
mesenteric vessels are in peril of ischemia because they frequently
originate exclusively from a miniscule aortic true lumen. The likelihood of developing clinically relevant dynamic branch vessel
compromise appears related in part to the area of the proximal
entry tear. Although the process of dynamic involvement is dependent on multiple factors, as a general rule, the more severe the
true lumen collapse, the larger or more circumferential the size of
the proximal primary entry tear. Management of more than one
ischemic vascular bed related to dynamic branch involvement and
Aortic Interventions
Endovascular aortic stent grafting is a less invasive alternative to
open surgery for selected patients with both thoracic and abdominal aneurysms. Recently, the application of similar technology for
management of acute aortic syndromes, including aortic dissection, has emerged as a focus of interest and study.
any new procedure, the key question is the determination of specific patient populations who may benefit from the new technique.
In this regard, the use of traditional classification parameters for
risk stratification of aortic dissection patients has advanced evaluation of the possible benefits and risks of endograft management.
Nearly all experience in endograft management of aortic
dissection has been with type B disease when there is exclusive
7,10–13,20,21
As with

involvement of the descending thoracic aorta. Experience with
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
endograft applications in type A dissection is limited to isolated
case reports. In the United States, type B aortic dissections constitute approximately 30% to 35% of all dissections. The initial risk
stratification of the type B dissection is made with the determination of the presence or absence of complications.
Medical management is the traditional treatment strategy for
uncomplicated acute aortic dissection. Current reports cite a
30-day mortality rate of approximately 10%.
22,23
Use of stent grafting
for stable uncomplicated patients with type B aortic dissection has
yet to realize any improvement in survival compared to traditional
medical therapy. Indeed, current conservative noninterventional
management of uncomplicated cases is associated with 1-year survival rates of around 80%. Such results may be hard to improve
upon with endograft therapy.
23,33
Stent Grafts for Uncomplicated
Type B Dissection
The Investigation of Stent Grafts in Patients with Type B Aortic
Dissection (INSTEAD) trial observed that elective stent graft placement in survivors of uncomplicated chronic type B dissection
does not improve 1-year survival and adverse event rates compared with medical therapy. Among the 140 patients randomized
in this prospective trial, 1-year survival was 91% compared with 97%
in patients randomized to medical therapy.
related mortality was not different, and the risk for the combined
endpoint of aorta-related death (rupture) and progression (including conversion or additional endovascular or open surgical intervention) was similar.
In the setting of complicated aortic dissection, medical management is associated with a high mortality rate, such that most patients
will undergo surgery to address life-threatening complications.
Depending on the patient's underlying medical conditions and the
nature of the complication(s), surgical mortality rates range from
between 30% and 60% or higher.
24,25
It is in these high-risk scenarios that an opportunity exists to establish a role for interventional
management. Thus the question becomes, What constitutes compli-
cated type B aortic dissection? There is no strict definition for this
category of disease, but traditionally it is relegated to two unambiguous disease manifestations: aortic rupture (
tomatic branch vessel involvement. These conditions are clear and
their diagnosis unequivocal. Other adverse effects of the dissection
process, such as uncontrollable hypertension, unrelenting pain,
34,35
Moreover, aorta-
Fig. 36-7) and symp-
2,4
and increasing pleural fluid, defy easy classification and do not
have uniform criteria for comparative assessment. These so-called
softer indications for intervention are commonly included as a
surgical indication in most published series of acute complicated
dissection.
8,26
Endograft Treatment of Complicated
Type B Dissection
The procedural goal for endovascular stent grafting in patients
with complicated acute type B aortic dissection is endograft elimination of blood flow entry into the proximal entry tear. Obliterating
the primary communication between the true lumen and the false
redirects pulsatile flow into the true lumen, promotes false lumen
thrombosis, and ultimately improves remodeling of the aorta by
increasing the dimensions of the true lumen while shrinking the
false lumen (
Fig. 36-8).
Specific procedural techniques vary depending on the precise
complication. Faced with dynamic branch vessel involvement
and clinically relevant obstruction compromising flow to one or
multiple branches, the procedural strategy focuses on unloading the aortic false lumen by increasing resistance to false
lumen inflow or decreasing resistance to its outflow. The former
is attempted by deploying an endograft over the proximal primary entry tear and rechanneling all flow into the true lumen.
Logistically, this typically involves placement of a 15-cm-long
(range 12-20 cm) stent graft from the nondissected segment of
aorta proximal to the primary intimal tear, commonly between
the origins of the left carotid and left subclavian arteries. This may
require intentional partial or complete coverage of the left subclavian origin. The distal extent of the device usually remains above
the diaphragm. The diameter of the implant selected is based on
the transaortic dimension of the nondissected aorta just proximal
to the dissection, rather than the size of the true lumen or transaortic diameter of the dissected segment.
Endovascular Treatment of Branch Vessel
Involvement
The outcomes of stent graft therapy for reversal of dynamic branch
vessel involvement are excellent, with procedural success in up
to 95% of cases and complete false lumen thrombosis in 85% of
patients.
freedom from aortic rupture and open repair.
7–9
These procedures are associated with 67.7% 5-year
9
Additionally, static
451
CH
36
EndovAsCulAR THERAPy foR AoRTiC dissECTion
A B C
FIGURE 367 Acute type B aortic dissection with rupture in a 68-year-old woman. A, Frontal chest radiograph upon presentation to emergency room
with severe back pain and hypertension that occurred while gardening. B, Axial computed tomography (CT) scan after contrast media administration shows typical
appearance of aortic dissection in mid-descending aorta. C, Repeat chest radiograph performed after transfer to referral facility 4 hours after initial study, with marked
interval change including opacification of left hemithorax from leaking blood.

452
CH
36
A
B
FIGURE 368 Treatment and follow-up imaging of type B aortic dissection with rupture. A, Aortograms pre- and post placement of a thoracic endograft
across mid-descending aorta entry tear of a type B dissection in the 68-year-old woman described in Figure 36-7. B, Series of axial computed tomography (CT ) images
obtained 1 week postendograft management of a type B dissection with rupture. Stent graft is in good position, and false lumen is thrombosed. Residual extravascular
blood and hematoma are evident.
branch involvement remote from the covered proximal aortic
entry tear may require separate targeted intervention to manage
residual ischemic compromise. This is especially important in
cases with no-reentry anatomy complicating static branch involvement. In these situations, endovascular branch intervention should
be provided emergently.
An alternative to endograft placement in dynamic branch
compromise is distal flap fenestration.
9,27
Percutaneous balloon fenestration of the aortic septum has replaced the operative procedure. Balloon fenestration of the septum is designed
to unload the aortic false lumen by decreasing the resistance to
outflow. Technically, initial transgression of the aortic flap with
a small cardiac transseptal TIPS needle and cannula usually is
performed from the small true lumen into the larger target of
the false channel. The site of the needle puncture commonly lies
within the infrarenal aorta at the level of the aortic bifurcation.
Once successful transgression of the septum is confirmed, a wire
is advanced across the flap and well into the targeted lumen.
Sequentially larger balloon dilation of the flap is performed until
a final size of between 20 and 25 mm is obtained.
Balloon fenestration causes a linear transverse tear in the flap
that allows greater mixture of blood between the two aortic channels and decompresses the true lumen. These effects must be
confirmed by aortography or intravascular ultrasound (IVUS) to
ensure relief of the dynamic pattern of branch obstruction. After
these two endovascular (endograft or fenestration) procedures,

imaging comparisons of the anatomical effects (with computed
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
tomography [CT], magnetic resonance imaging [MRI] or IVUS),
including changes in the size of the aortic lumens, typically demonstrate a more dramatic result following endograft management.
Specifically, the magnitude of true lumen expansion with stent
grafting is greater than that observed after distal flap fenestration.
Because false lumen fenestration promotes flow in the false lumen,
whereas endograft placement promotes false lumen thrombosis,
the latter is thought to be a superior method to minimize late aneurysm formation. Consequently, the opportunities for percutaneous
balloon fenestration are decreasing now that thoracic endograft
availability has improved. Fenestration is typically limited to situations when stent grafts are unavailable or when the specific aortic
anatomy is unsuitable for endograft placement.
Aortic Rupture
Rupture that complicates aortic dissection is an interventional
imperative.
focus on preventing exsanguination. Both open surgical and endovascular therapies are associated with high mortality and morbidity rates in the presence of aortic rupture. Recent reports suggest
28,29
The procedural considerations for aortic rupture
that endovascular approaches permit treatment of more patients,
including older and less fit individuals whose operative risk in this
setting is prohibitive.
21,28,29
Localizing the precise site of rupture noninvasively is not always
possible. The point of rupture through the false lumen wall may
be evident by the presence of contrast enhancement beyond the
anticipated aortic border, though this occurs typically in the setting of severe hemodynamic instability or shock (
Fig. 36-9). More
commonly, a periaortic, mediastinal, and/or pleural collection is
evident on CT imaging, which has an appearance and attenuation value consistent with hematoma or complex fluid. This abnormality may be most prominent around a focal aortic segment or
extend diffusely over a wider zone.
The goal of endograft management for aortic rupture is coverage of the proximal entry tear, with isolation of the false lumen,
to ensure false lumen obliteration and expeditious thrombosis.
It is thrombosis of the false lumen that prevents aortic leakage
of blood. To facilitate rapid false lumen thrombosis, the overall
endograft coverage of the aorta is often longer than that used for
other thoracic pathologies. By extending the length of coverage
(20-30 cm) to at least the level of the diaphragm or celiac trunk,
the aortic septum is braced by the stent in the true lumen, and the
453
CH
36
EndovAsCulAR THERAPy foR AoRTiC dissECTion
A
B
FIGURE 369 Endograft management of aortic dissection with rupture. A, Axial and sagittal computed tomography (CT ) images of 59-year-old man with
acute type B dissection with primary tear distal to left subclavian artery and retrograde extension into the proximal arch (DeBakey class IIID) complicated by rupture.
Axial projection shows a large quantity of extravascular fluid, and sagittal image shows a faint wisp of contrast extravasation above aorta, just distal to subclavian artery.
B, Three views from the stent graft procedure, with the left and middle panels before device placement, and the right panel after deployment. A good result is evident,
with contrast opacification of the true lumen only.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
